Western blotting showed that NCTD markedly reduced the level of c-FLIP and enhanced Birinapant-triggered caspase-3 activation and PARP cleavage in primary breast cancer cells of case 5, suggesting a similar mechanism as in established cancer cell lines (Figure 6B). The gene discussed is CFLAR; the disease is cancer.